Bayer AG

Industry / private company


Location: Leverkusen, Germany (DE) DE

ISNI: 0000000403744101

ROR: https://ror.org/04hmn8g73

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study (2024) Bouhassira D, Tesfaye S, Sarkar A, Soisalon-Soininen S, Stemper B, Baron R Journal article Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes (2023) Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder R, Anker SD, Filippatos G, et al. Journal article Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine (2023) Schlosser P, Scherer N, Grundner-Culemann F, Monteiro-Martins S, Haug S, Steinbrenner I, Uluvar B, et al. Journal article Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes (2022) Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, et al. Journal article CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE) (2022) Green JB, Mottl AK, Bakris G, Heerspink HJL, Mann JFE, Mcgill JB, Nangaku M, et al. Journal article Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study (2022) Mielke J, Trucks-Jansen H, Schurmann C, Kotsis F, Koettgen A, Schneider M, Eckardt KU, et al. Journal article Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study. (2022) Kubitza D, Heckmann M, Distler J, Koechel A, Schwers S, Kanefendt F Journal article CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article, Review article CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article
1 2 3